Ph1b/2 Elacestrant + Combo Met Breast Cancer (ELEVATE)
Phase I/II Clinical Trial
A Phase 1b/2 Open-Label Umbrella Study to Evaluate Safety and Efficacy of Elacestrant in Various Combinations in Patients with Metastatic Breast Cancer (ELEVATE) (STML-ELA-0222)